World
The transaction includes the acquisition of the medical business of Precision Concepts International ("PCI") as well as Precision Concepts Group ("PCG"), h...
May 19, 2023 | News
- ATG-031, discovered and developed in-house by Antengene, is the world's first anti-CD24 antibody to advance to the clinic in oncolog...
May 18, 2023 | News
With more than 80% of its rapidly growing revenues tied to large molecule applications, Wyatt accelerates Waters' ability to build a high-growth business i...
May 17, 2023 | News
What is the significance of the first end-to-end mRNA process contract development and manufacturing organization (CDMO) establishment in Australia?  ...
May 17, 2023 | News
With +80 US/EU peer reviewed publications, the oCelloScope is a one-of-a-kind workhorse in many microbial applications. In AST,...
May 17, 2023 | News
Lonza launches the TheraPEAK® T-VIVO® Cell Culture Medium with a novel chemically defined formulation developed to optimize and streamlin...
May 16, 2023 | News
Discover how the combined technical expertise, talent, and portfolio offerings of these two distinguished brands are driving the next generation of medicin...
May 12, 2023 | News
Sonelokimab is MoonLake Immunotherapeutics' investigational anti-IL-17 A/F Nanobody technology designed to more directly target sites of inflammation and p...
May 11, 2023 | News
Increasing localized access can provide faster results for patients while potentially improving patient outcomes Agreement aims to enable greater access t...
May 10, 2023 | News
This Phase 2 trial is evaluating three vaccine candidates: COVID-Influenza Combination, stand-alone influenza and high-dose COVID Preliminary topline im...
May 10, 2023 | News
Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges Tru...
May 09, 2023 | News
BSI-038 is an anti-CD40 agonistic monoclonal antibody, discovered through Biosion's H³ antibody discovery platform. BSI-038 exhibits enhanced bin...
May 09, 2023 | News
--Respiratory syncytial virus (RSV) infection treatment remains huge unmet medical needs and there is no effective drug for treatment globally so far --Do...
May 09, 2023 | News
Nous-209 has been developed using the Nouscom's viral vector platform, which includes adenoviral and Modified Vaccinia Ankara (MVA) vectors, with MVA vecto...
May 04, 2023 | News
Most Read
Bio Jobs
News